11230sek
-1,0 %
Date:2026-09-07Time:11:33:46Latest report:Q2-2026List:Mid CapTicker:BIOG B
Market Cap:11 360 msekEnterprise Value:10 914 msekNet Sales:1 581 msekEarnings:347,2 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:113,00
MA50:115,90
MA200:113,96
Price/MA200:-0,8 %
RSI (14):44,7
Price/MA50:-2,5 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.